首页 | 本学科首页   官方微博 | 高级检索  
检索        

黄芩素对肝癌H22荷瘤小鼠的抑瘤作用研究
引用本文:崔琨,范公忍,姬胜杰,侯保全.黄芩素对肝癌H22荷瘤小鼠的抑瘤作用研究[J].中国药房,2012(31):2897-2899.
作者姓名:崔琨  范公忍  姬胜杰  侯保全
作者单位:[1]商丘市长征人民医院肝病科,河南商丘476000 [2]北京军区总医院肝病研究所,北京100700
摘    要:目的:研究黄芩素对肝癌H22荷瘤小鼠的抑瘤作用。方法:以H22肝癌细胞接种于正常小鼠左前肢腋窝皮下复制肝癌H22荷瘤模型。实验分为模型对照、环磷酰胺(30mg·kg-1)和黄芩素高、中、低剂量(80、40、20mg·kg-1)组。灌胃给药,每天1次,连续15d。末次给药后处死小鼠,剥离完整的肿瘤组织称重,并计算肿瘤抑制率;流式细胞仪分析细胞周期分布和凋亡率;按试剂盒说明书测定肿瘤组织中半胱氨酸蛋白酶(Caspase)-3的活性;RT-PCR测定瘤组织中B细胞淋巴瘤/白血病-2(Bcl-2)、Bcl-2相关X蛋白(Bax)的mRNA表达水平。结果:高、中剂量黄芩素可显著抑制模型小鼠体内肿瘤生长(P<0.01或P<0.05),抑制率分别为61.63%和44.65%;可显著提高G0/G1期细胞百分比(P<0.05),并减少S期细胞(P<0.01或P<0.05)。与模型对照组比较,黄芩素高、中、低剂量组细胞凋亡率显著提高(P<0.01或P<0.05)。高、中剂量黄芩素可显著增强肿瘤组织中Capcase-3活性(P<0.01或P<0.05),抑制Bcl-2mRNA表达(P<0.01或P<0.05);高剂量黄芩素可显著提高肿瘤组织中BaxmRNA表达(P<0.05)。结论:黄芩素可促进肝癌H22荷瘤小鼠肿瘤细胞的凋亡,其机制可能与增强Capcase-3活性、提高Bax表达,并抑制Bcl-2表达有关。

关 键 词:黄芩素  肝癌  抗肿瘤  细胞凋亡

Anti-tumor Effects of Baicalein on H22 Hepatocarcinoma-bearing Mice
CUI Kun,JI Sheng-jie,HOU Bao-quan.Anti-tumor Effects of Baicalein on H22 Hepatocarcinoma-bearing Mice[J].China Pharmacy,2012(31):2897-2899.
Authors:CUI Kun  JI Sheng-jie  HOU Bao-quan
Institution:(Dept. of Hepatology, Shangqiu Long March People's Hospital of Henan province, Henan Shangqiu 476000, China) FAN Gong-ren(Institute of Liver Diseases,General Hospital of Beijing Military Region Research,Beijing 100700, China)
Abstract:OBJECTIVE: To investigate the anti-tumor effects of baicalein on H22 hepatocarcinoma-bearing mice. METHODS: H22 tumor-bearing mice model was induced by H22 cell vaccination in normal mouse forelimb left axillary subcutaneous. H22 hepa- tocarcinoma-bearing mice model was induced and randomized into 5 groups: model control group, cytoxan group (30 mg. kg^-1), baicalein high-dose,medium-dose and low-dose groups (80,40,20 mg.kg^-1). They were given medicine intragastrically once a day for consecutive 15 days. After the last administration, all mice were sacrificed for weighing the tumor and calculating the tumor in- hibition rate. The cell cycle and the apoptosis rate were analyzed by flow cytometry. The activity of Caspase-3 was detected by a commercial kit. The mRNA expression levels of Bax and Bcl-2 were measured by RT-PCR. RESULTS: High-dose and medi- um-dose baicalein (80,40 mg. kg^-1) could inhibit the growth of tumor in model mice significantly(P〈0.01 or P〈 0.05) with inhibi- tion rates of 61.63% and 44.65% respectively; the ratio of FCM G0/G1 cells in high-dose and medium-dose baicalein (80,40 mg. kg^-1) groups was significantly increased (P〈0.01 or P〈0.05), and the ratio of FCM S cells was significantly reduced (P〈0.05). Compared with model control group, the apoptosis rates in baicalein low-dose, medium-dose and high-dose groups were increased significantly(P〈0.01 or P〈0.05).The activity of Caspase-3 in medium-dose and high-dose groups and the mRNA expression levels of Bax in high-dose groups were increased significantly, and the mRNA expression of Bcl-2 in medium-dose and high-dose groups was decreased in baicalein groups. CONCLUSION: Baicalein is able to promote the apoptosis of tumor cells in mice, and the mechanism maybe involved in enhancing the activity of Caspase-3, increasing the mRNA expression of Bax and decreasing the mRNA expression of Bcl-2.
Keywords:Baicalein  Hepatocarcinoma  Antitumor  Cell apoptosis
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号